Ensemble Therapeutics is focused on the discovery and development of breakthrough small molecule therapies for patients with cancer.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 12, 2004 | Series A | $15M | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series A |